Languages:
 

Table 4 - NHPs used for different purposes in fundamental biology research
Species Human cardiovascular diseases Human nervous and mental disorders Human cancer Other human diseases Studies specific to animal diseases Total
Prosimians 0 383 0 0 0 383
NW primates 58 204 2 810 0 1074
OW primates 53 167 179 2882 9 3290
Total 111 754 181 3692 9 4747
% of total NHP use 2.33 % 15.9 % 3.81 % 77.8 % 0.19 %  
% total animal use 0.026 % 0.05 % 0.020 % 2.28 % 0.006 % 0.068 %

Source: SCHER,  The need for non-human primates in biomedical research, production and testing of products and devices (2009),
Section 3.1.1 Overview on the use of NHPs in research and testing, p. 7 -11.

Related publication:
Non-human primates homeNon-human primates in research and safety testing
Other Figures & Tables on this publication:

Use of primates in EU research and safety testing

Table 1 - Changes in NHP use between 2002 and 2005 in the EU

Table 2 - NHP used in different EU countries

Table 3 - NHP used for different purposesSee below for description of categories

Table 4 - NHPs used for different purposes in fundamental biology research

digest
Published under the authority of the GreenFacts Scientific Board.
Keep in touch, subscribe:
13-7-2023
Copyright © GreenFacts 2001–2023 GreenFacts® is a registered trademark of Cogeneris sprl. Design: Morris & Chapman